These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25542698)

  • 1. Quantitative analysis of CDKN2A methylation, mRNA, and p16(INK4a) protein expression in children and adolescents with Burkitt lymphoma: biological and clinical implications.
    Robaina MC; Faccion RS; Arruda VO; de Rezende LM; Vasconcelos GM; Apa AG; Bacchi CE; Klumb CE
    Leuk Res; 2015 Feb; 39(2):248-56. PubMed ID: 25542698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma.
    Klangby U; Okan I; Magnusson KP; Wendland M; Lind P; Wiman KG
    Blood; 1998 Mar; 91(5):1680-7. PubMed ID: 9473234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
    J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.
    Robaina MC; Mazzoccoli L; Arruda VO; Reis FR; Apa AG; de Rezende LM; Klumb CE
    Exp Mol Pathol; 2015 Apr; 98(2):200-7. PubMed ID: 25746661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
    van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ
    Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
    Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
    Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
    Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
    Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
    Tang S; Luo H; Yu J; Yang D; Shu J
    Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
    Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
    Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children.
    Wilda M; Bruch J; Harder L; Rawer D; Reiter A; Borkhardt A; Woessmann W
    Leukemia; 2004 Mar; 18(3):584-8. PubMed ID: 14712292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt lymphoma cell lines.
    Roberti A; Rizzolio F; Lucchetti C; de Leval L; Giordano A
    Cell Cycle; 2011 Jan; 10(1):127-34. PubMed ID: 21200153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RB (pRb2/p16) and p53 (p14/p53/p21) tumor-suppressor pathways in endemic Burkitt lymphoma.
    Kalungi S; Wabinga H; Bostad L
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):e54-9. PubMed ID: 21127431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16INK4a.
    Wu DS; Shen JZ; Yu AF; Fu HY; Zhou HR; Shen SF
    Oncol Rep; 2013 Dec; 30(6):2969-75. PubMed ID: 24064951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma.
    Zainuddin N; Kanduri M; Berglund M; Lindell M; Amini RM; Roos G; Sundström C; Enblad G; Rosenquist R
    Leuk Res; 2011 Apr; 35(4):438-43. PubMed ID: 21035853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A promoter hypermethylation in astrocytomas is associated with age and sex.
    Alves MK; Faria MH; Neves Filho EH; Ferrasi AC; Pardini MI; de Moraes Filho MO; Rabenhorst SH
    Int J Surg; 2013; 11(7):549-53. PubMed ID: 23721661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
    Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
    Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.